APRIL/TNFSF13 ELISA DY884B from R&D Systems, a Bio-Techne Brand

Product Specs
ItemAPRIL/TNFSF13 ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $890.00Supplier Page View Company Product Page
Catalog NumberDY884B
Quantity1 Kit (for 15 Plates)
ApplicationsELISA
Detection Range31.20 - 2000 pg/mL
ReactivityHuman
Detection TargetAPRIL/TNFSF13
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene NameTNF superfamily member 13
NCBI Gene AliasesAPRIL, CD256, TALL-2, TALL2, TNLG7B, TRDL-1, UNQ383/PRO715, ZTNF2

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 15 Plates)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1Scand J ImmunolApril 1, 2025Isil Kucuka, Dorsa Iraji, Sarah Braun, Lars Breivik, Anette S. B. Wolff, Eystein S. Husebye, Bergithe E. Oftedalby the Human BAFF/Blys/TNFSF13B Quantikine ELISA kit (DBLYS0B) and Human APRIL/TNFSF13 DuoSet ELISA (DY884B), both from R&D systems (Abingdon, United Kingdom) in accordance with the manufacturer's protocol. 2.5

(2) A first‐in‐human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adultsClinical and Translational ScienceNovember 4, 2024Rupert Davies, Stanford L. Peng, Jason Lickliter, Kristi McLendon, Amanda Enstrom, Allison G. Chunyk, Lori Blanchfield, NingXin Wang, Tiffany Blair, Heather M. Thomas, et al.assays Serum f/t APRIL were determined using commercially available reagents or kits (R&D Systems, cat #DY884B; MSD, cat #D219C‐3). F/t BAFF were quantified by ECLIA using proprietary monoclonal antibodies. Testing

(3) Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in SARS-CoV-2 infection and COVID-19 severityHeliyonJanuary 1, 2023Alturaiki W, Alkadi H, Alamri S, Awadalla ME, Alfaez A, Mubarak A, Alanazi MA, Alenzi FQ, Flanagan BF, Alosaimi B.CCL21, CCL19, CXCL12, and CXCL13 were quantified using ELISA kits (DuoSet ELISA DY814-05, DY124-05, DY884B, DY366, DY361, DY350, and DY801, respectively; R&D Systems, Minneapolis, MN, USA) according to the manufacturer's

(4) Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphomaThe Journal of experimental medicineSeptember 5, 2022Miao YR, Thakkar K, Cenik C, Jiang D, Mizuno K, Jia C, Li CG, Zhao H, Diep A, Xu Y, et al.files (DICOM converter; Bruker). ELISA Serum and cell lysate expression of human APRIL (cat. no. DY884B; R&D Systems), human BAFF (cat. no. DBLYS0B; R&D Systems), mouse APRIL (cat. no. MBS738004; My BioSource),

(5) A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential ThrombocythemiaJournal of clinical medicineAugust 9, 2022Bolkun L, Tynecka M, Wasiluk T, Piszcz J, Starosz A, Grubczak K, Moniuszko M, Eljaszewicz A.

(6) Binary MoS2 nanostructures as nanocarriers for amplification in multiplexed electrochemical immunosensing: simultaneous determination of B cell activation factor and proliferation-induced signal immunity-related cytokinesMicrochimica ActaApril 1, 2022Beatriz Arévalo, Marina Blázquez-García, Alejandro Valverde, Verónica Serafín, Ana Montero-Calle, Guillermo Solís-Fernández, Rodrigo Barderas, Susana Campuzano, Paloma Yáñez-Sedeño, José M. Pingarrónand human APRIL standard were from the Human APRIL/TNFSF13 DuoSet ELISA from R&D Systems (Cat. No. DY884B). Biotin was from Gerbu (Lot. 280,611). Selectivity was checked against human hemoglobin (HB, Cat. No.

(7) Antibody microarray analysis of amniotic fluid proteomes in women with cervical insufficiency and short cervix, and their association with pregnancy latency lengthPloS oneJanuary 1, 2022Hong S, Park KH, Lee YE, Lee JE, Kim YM, Joo E, Cho I.

(8) Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi ArabiaSaudi journal of biological sciencesDecember 1, 2021Alturaiki W, Mubarak A, Mir SA, Afridi A, Premanathan M, Mickymaray S, Vijayakumar R, Alsagaby SA, Almalki SG, Alghofaili F, et al.

(9) Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of TherapyFrontiers in pharmacologyJanuary 1, 2021Piantoni S, Regola F, Masneri S, Merletti M, Lowin T, Airò P, Tincani A, Franceschini F, Andreoli L, Pongratz G.

(10) Immune and Inflammatory Proteins in Cord Blood as Predictive Biomarkers of Retinopathy of Prematurity in Preterm InfantsInvestigative ophthalmology & visual scienceSeptember 3, 2019Park YJ, Woo SJ, Kim YM, Hong S, Lee YE, Park KH.

(11) B cell maturation antigen-specific CAR T cells are clinically active in multiple myelomaThe Journal of clinical investigationMarch 21, 2019Cohen AD, Garfall AL, Stadtmauer EA, Melenhorst JJ, Lacey SF, Lancaster E, Vogl DT, Weiss BM, Dengel K, Nelson A, et al.APRIL concentrations in serum was performed by ELISA using antibody sets for human BCMA (DY193), APRIL (DY884B), and BAFF (DT124-05) from R&D Systems. See Supplemental Methods for details. Flow cytometric assessment

(12) BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosusCytokineFebruary 1, 2019Salazar-Camarena DC, Ortíz-Lazareno P, Marín-Rosales M, Cruz A, Muñoz-Valle F, Tapia-Llanos R, Orozco-Barocio G, Machado-Contreras R, Palafox-Sánchez CA.

(13) Abnormal differentiation of B cells and megakaryocytes in patients with Roifman syndromeThe Journal of allergy and clinical immunologyAugust 1, 2018Heremans J, Garcia-Perez JE, Turro E, Schlenner SM, Casteels I, Collin R, de Zegher F, Greene D, Humblet-Baron S, Lesage S, et al.

(14) Serum BAFF in Indian patients with IIM: a retrospective study reveals novel clinico-phenotypic associations in children and adultsClinical rheumatologyMay 1, 2018Gupta L, Chaurasia S, Srivastava P, Dwivedi S, Lawrence A, Misra R.

(15) Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitisPloS oneJanuary 1, 2018Kathamuthu GR, Moideen K, Banurekha VV, Nair D, Sridhar R, Baskaran D, Babu S.

(16) Modulation of Mycobacterium tuberculosis-specific humoral immune responses is associated with Strongyloides stercoralis co-infectionPLoS neglected tropical diseasesMay 1, 2017Anuradha R, Munisankar S, Bhootra Y, Dolla C, Kumaran P, Nutman TB, Babu S.

(17) Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritisClinical and experimental immunologyMarch 1, 2017Phatak S, Chaurasia S, Mishra SK, Gupta R, Agrawal V, Aggarwal A, Misra R.

(18) Inflamm-aging influences immune cell survival factors in human bone marrowEuropean journal of immunologyMarch 1, 2017Pangrazzi L, Meryk A, Naismith E, Koziel R, Lair J, Krismer M, Trieb K, Grubeck-Loebenstein B.

(19) Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral EncephalitisPloS oneJanuary 1, 2016Kothur K, Wienholt L, Mohammad SS, Tantsis EM, Pillai S, Britton PN, Jones CA, Angiti RR, Barnes EH, Schlub T, et al.

(20) Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemiaStem cells and developmentMay 1, 2013Pontikoglou C, Kastrinaki MC, Klaus M, Kalpadakis C, Katonis P, Alpantaki K, Pangalis GA, Papadaki HA.